Studies indicate that modifications that enhance the time a drug remains bound to its target, or residence time, may lead to better diagnostic and therapeutic agents.
Results 1 to 1 of 1
MEDiscuss • Medical News • Lengthening time a drug remains bound to a target may lead to improving diagnostics, therapy
- April 25th, 2010 #1Bot
- Member since
- Jul 2007
- Posts
- 20,744
Lengthening time a drug remains bound to a target may lead to improving diagnostics, therapy
QuoteRelated Posts
-
Improving gene therapy for heart disease, cancer
By MedBot in forum Medical NewsReplies: 0Last Post: October 12th, 2011, 06:02 PM -
Referring doctors increasingly aware of deep brain stimulation therapy; more work remains
By MedBot in forum Medical NewsReplies: 0Last Post: August 16th, 2011, 06:06 PM -
Cancer drug target is promising lead for new TB treatments
By MedBot in forum Medical NewsReplies: 0Last Post: November 17th, 2010, 02:44 AM -
Catalyst sandwich: Synthetic PCR mimic could lead to highly sensitive medical, environmental diagnostics
By MedBot in forum Medical NewsReplies: 0Last Post: September 30th, 2010, 08:16 PM -
Novel target for existing drug may improve success of radiation therapy
By MedBot in forum Medical NewsReplies: 0Last Post: September 20th, 2010, 04:44 AM
Posting Permissions
The information provided on this site is meant to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician
© 2007 - 2012 MEDiscuss | Powered by vBulletin® | Search Engine Optimization by vBSEO | vB skin by CompleteVB
© 2007 - 2012 MEDiscuss | Powered by vBulletin® | Search Engine Optimization by vBSEO | vB skin by CompleteVB
All times are GMT. The time now is 07:52 AM.